Provention Bio, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and solutions to prevent immune-mediated diseases. Its product portfolio includes vaccines to prevent CVB infections and treatments for T1D and lupus. The company also has license agreements and strategic collaborations with Amgen Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.